AGN - Allergan Plc Profile, Stock Quotes, Financial Analysis, Charts, Fundamentals

Company Name or Ticker Symbol

Search for other Categories

Allergan Plc (AGN)

Other Ticker:

Sector • Healthcare Industry • Biotechnology & Drugs

Industry • Biotechnology & Drugs

Sector • Healthcare

Price: $152.6900 $3.43

2.298%

Day's High:	$ 153.98	Week Perf:	5.59 %
Day's Low:	$ 149.59	30 Day Perf:	0.28 %
Volume (M):	1,934	52 Wk High:	$ 197.00
Volume (M$):	$ 295,302	52 Wk Avg:	$ 167.94
Open:	$ 149.84	52 Wk Low:	$ 125.84

AGN Charts & Quotes

You need to upgrade your Flash Player

Description of Company's Segments

Market Capitalization (Millions $)	51,762
Shares Outstanding (Millions)	339
Employees	10,500
Revenues (TTM) (Millions $)	16,034
Net Income (TTM) (Millions $)	2,333
Cash Flow (TTM) (Millions $)	-425
Capital Exp. (TTM) (Millions $)	291

Allergan Plc
Allergan, Inc. is a technology-driven, global health care company that develops and commercializes specialty pharmaceutical products for the ophthalmic, neurological, dermatological and other specialty markets. We are a pioneer in specialty pharmaceutical research, targeting products and technologies related to specific disease areas such as glaucoma, retinal disease, dry eye, psoriasis, acne and movement disorders. Additionally, we develop and market aesthetic-related pharmaceuticals and over-the-counter products.

AGN is expected to report next financial results on February 04, 2019.

Allergan Plc's Segments


Eye Care Pharmaceuticals	Segment	46.68 %	of total Revenue
Skin Care	Segment	7.18 %	of total Revenue
BOTOX/Neuromuscular	Segment	31.2 %	of total Revenue
Total Specialty Pharmaceuticals	Segment	85.06 %	of total Revenue
Alphagan P & Alphagan	Segment	7.33 %	of total Revenue
Lumigan	Segment	9.39 %	of total Revenue
Restasis	Segment	16.38 %	of total Revenue
Latisse	Segment	1.45 %	of total Revenue
Breast Aesthetics	Segment	5.27 %	of total Revenue
Facial Aesthetics	Segment	9.22 %	of total Revenue
Total Medical Devices	Segment	14.94 %	of total Revenue

• View Complete Report

	Company Estimates
	• Revenue Outlook Allergan Plc does not provide revenue guidance. • Earnings Outlook Allergan Plc does not provide earnings estimates.

Geographic Revenue Dispersion
United States	65.79 %
Europe	20.53 %
Asia Pacific	7.46 %
Latin America	5.56 %
Other	0.66 %

News

Royal Dutch Shell Plc

Sales and Earnings Unchanged

In the third quarter reached break-even of $0.00 per share compare to $0.00 a year ago and from $0.00 per share from the previous quarter.

Sales remained unchanged to $100.15 billions from $0.00 millions in the same quarter a year ago and sequentially by -67.89 % from $311.87 billions.

Alio Gold Inc.

announced forth quarter operating surplus of $22.066 millions

In the forth quarter reached break-even of $0.00 per share compare to $0.00 a year ago and from $0.00 per share from the previous quarter.

Sales remained unchanged by 0 % to $179.62 millions from $179.62 millions in the same quarter a year ago and sequentially from $0.00 millions.

Steel Connect, Inc.

Deficit Bigger Than a Year Ago, Topline Tumbles

reported disastrous first quarter, where Sales faded by -66.66 % to $215.13 millions and loss per share has widen to $-0.13, from the same quarter a year ago.

Business First Bancshares, Inc.

EPS Drops, Topline Tumbles

In the third quarter earnings per share plummeted by -45.9 % of $0.33 per share compare to $0.61 a year ago and eps remained unchanged from $0.33 per share from the previous quarter.

Revenues fell sharply by -63.54 % to $16.68 millions from $45.75 millions in the same quarter a year ago and sequentially Revenues increased by 1.04 % from $16.51 millions.

Nucana Plc

announced forth quarter operating income of $17.673 millions

In the forth quarter reached break-even of $0.00 per share compare to $-0.08 a year ago and from $0.00 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

AGN's Valuation	Current
Price to Earnings PE Ratio (TTM)	22.73
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	3.23
Price to Sales (Expected)	-
Price to Book	0.73
PEG (TTM)	-

AGN's Financial Strength	Current
Quick Ratio	0.19
Working Capital Ratio	0.92
Leverage Ratio (MRQ)	1.59
Total Debt to Equity	0.33
Interest Coverage (TTM)	-
Debt Coverage (TTM)	-

Per Share	Current
Earnings (TTM)	6.72 $
Revenues (TTM)	47.3 $
Cash Flow (TTM)	-1.25 $
Cash	3.57 $
Book Value	208.03 $
Dividend (TTM)	10.72 $

AGN's Efficiency	Current
Revenue per Employee (TTM)	1,527,029
Net Income per Employee (TTM)	222,181
Receivable Turnover Ratio (TTM)	5.76
Inventory Turnover Ratio (TTM)	2.38
Asset Turnover Ratio (TTM)	0.14

AGN's Profitability Ratio	Current
Gross Margin	84.74 %
Operating Margin	6.58 %
Net Margin	-
Net Cash Flow Margin	-
Effective Tax Rate (TTM)	-

Management Effectiveness	Current
Return On Assets (TTM)	2.1 %
Return On Investment (TTM)	1.28 %
Return On Equity (TTM)	3.24 %
Dividend Yield	6.41 %
Payout Ratio (TTM)	159.56 %

AGN's Valuation
Price to Earnings PE Ratio (TTM)	22.73
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	3.23
Price to Sales (Expected)	-
Price to Book	0.73
PEG (TTM)	-

AGN's Financial Strength
Quick Ratio	0.19
Working Capital Ratio	0.92
Leverage Ratio (MRQ)	1.59
Total Debt to Equity	0.33
Interest Coverage (TTM)	-
Debt Coverage (TTM)	-

Per Share
Earnings (TTM)	6.72 $
Revenues (TTM)	47.3 $
Cash Flow (TTM)	-1.25 $
Cash	3.57 $
Book Value	208.03 $
Dividend (TTM)	10.72 $

• View Valuation Comparisons

• View Growth Rates Comparisons

AGN's Efficiency
Revenue per Employee (TTM)	1,527,029
Net Income per Employee (TTM)	222,181
Receivable Turnover Ratio (TTM)	5.76
Inventory Turnover Ratio (TTM)	2.38
Asset Turnover Ratio (TTM)	0.14

AGN's Profitability Ratio
Gross Margin	84.74 %
Operating Margin	6.58 %
Net Margin	-
Net Cash Flow Margin	-
Effective Tax Rate (TTM)	-

Management Effectiveness
Return On Assets (TTM)	2.1 %
Return On Investment (TTM)	1.28 %
Return On Equity (TTM)	3.24 %
Dividend Yield	6.41 %
Payout Ratio (TTM)	159.56 %

• View Efficiency Comparisons

• View Profitability Comparisons

• View Management Effectiveness

Customers Net Income grew by	AGN's customers Net margin grew to
19.04 %	4.25 %

• Customers Performance

• Customers Expend.

• Customers Efficiency

• List of Customers

You need to upgrade your Flash Player

Reports on Competition

List of Competitors

Competitors by Segment

Segment Growth

Growth Rates

Suppliers At a Glance

List of Suppliers

Suppliers Performance

Major Competitors

Stock performance

5 Days	Decrease / Increase

AMGN	-0.61%
BIIB		4.04%
PFE	-1.61%
MRK	-1.96%
JNJ	-0.46%
JFIL	-100%
• View Complete Report

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar MU's Profile Stock Price MU's Financials Business Description Fundamentals Charts & Quotes MU's News Suppliers MU's Competitors Customers & Markets Economic Indicators MU's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Free Stock Market News Feeds

Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071

AGN Company Profile

Sales and Earnings Unchanged

announced forth quarter operating surplus of $22.066 millions

Deficit Bigger Than a Year Ago, Topline Tumbles

EPS Drops, Topline Tumbles

announced forth quarter operating income of $17.673 millions